| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |